阻断PD-1通过激活IFN-γ和抑制IL-10减轻脓毒症后曲霉感染
该研究采用盲肠结扎穿刺(CLP)小鼠脓毒症模型,于CLP后第5天静脉接种烟曲霉孢子,模拟脓毒症后免疫耗竭状态下的继发曲霉感染。在抗真菌药两性霉素B基础上加用抗PD-1治疗,可减轻血液和内脏真菌负荷并提高生存率,而单用两性霉素B无效。机制上伴随脾细胞CD86表达增强、血清IFN-γ升高和IL-10降低,活化T细胞产生IFN-γ增多、IL-10减少。作者认为辅助抗PD-1治疗可能成为致死性真菌感染的高级免疫治疗策略。
要点
- CLP小鼠脓毒症后第5天静脉接种烟曲霉孢子,单用两性霉素B未能有效治疗继发曲霉感染。
- 两性霉素B联合抗PD-1治疗降低血液和内脏真菌负荷,并提高继发曲霉感染小鼠生存率。
- 抗PD-1治疗伴随脾细胞CD86表达增强、血清IFN-γ升高和IL-10降低。
- 抗PD-1处理小鼠的活化T细胞产生IFN-γ增多、IL-10减少。
- 作者认为辅助抗PD-1治疗可能成为致死性真菌感染的有前景免疫治疗策略。
适用人群与场景
- 盲肠结扎穿刺(CLP)小鼠脓毒症模型,于CLP后第5天静脉接种烟曲霉孢子模拟脓毒症后继发曲霉感染。
处置流程与药物剂量
- CLP后第5天静脉接种烟曲霉孢子,给予两性霉素B治疗,并联合或不联合抗PD-1治疗。
研究设计与关键结果
- 单用两性霉素B未能有效治疗CLP小鼠继发曲霉感染。
- 两性霉素B联合抗PD-1治疗降低血液和内脏真菌负荷,并提高继发曲霉感染小鼠生存率。
- 抗PD-1治疗伴随脾细胞CD86表达增强、血清IFN-γ升高和IL-10降低。
- 抗PD-1处理小鼠的活化T细胞产生IFN-γ增多、IL-10减少。
证据类型、等级与局限
- 证据类型:小鼠实验研究(CLP脓毒症模型)。
- 作者结论:阻断PD-1可能通过上调CD86表达和IFN-γ产生、抑制IL-10产生,重新激活耗竭的抗原提呈细胞和T细胞,从而减轻继发曲霉感染。
- 作者认为辅助抗PD-1治疗可能成为致死性真菌感染的有前景免疫治疗策略。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文为小鼠实验研究,作者认为辅助抗PD-1治疗可能成为致死性真菌感染的有前景免疫治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Nosocomial aspergillosis in patients with sepsis has emerged in the past few years. Blockade of PD-1/PD-L pathway has tended to become a promising therapeutic strategy as it improved the outcome of bacterial sepsis and postsepsis secondary fungal infection. Recently, the controversial effects of PD-1 blockade on infectious diseases, including aspergillosis, have been demonstrated; therefore, the efficacy of anti-PD-1 drug still remains to be elucidated.
METHODS: Cecal ligation and puncture (CLP) was conducted as a mouse sepsis model. Aspergillus fumigatus spores were intravenously inoculated on day 5 post-CLP, when the immune cells succumbed to exhaustion. Amphotericin B was medicated together with or without anti-PD-1 treatment after Aspergillus infection.
RESULTS: Amphotericin B alone was not effective to treat the CLP-mice with secondary aspergillosis. In contrast, antifungal medication with the adjunctive anti-PD-1 treatment attenuated the fungal burdens in blood and internal organs, and improved the survival rate of the mice with secondary aspergillosis. These outcomes of PD-1 blockade were concurring with the enhanced CD86 expression on splenocytes, the augmented serum IFN-γ, and the dampened IL-10. Activated T cells from anti-PD-1-treated mice also highly increased IFN-γ and diminished IL-10 production.
CONCLUSION: The blockade of PD-1 on postsepsis aspergillosis presumably reinvigorated exhausted antigen-presenting cells and T cells by upregulating CD86 expression and IFN-γ production, and dampened IL-10 production, which consequently leaded to the attenuation of secondary aspergillosis. The adjunctive anti-PD-1 therapy may become a promising strategy for the advanced immunotherapy against lethal fungal infection.
参考来源
- Vu CTB, Thammahong A, Yagita H, et al. Blockade Of PD-1 Attenuated Postsepsis Aspergillosis Via The Activation of IFN-γ and The Dampening of IL-10. Shock. 2020. PMID: 31306346. doi:10.1097/SHK.0000000000001392
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。